drugset / Trial / NCT03183570
Detection of Integrin avb6 in IPF, PSC, and COVID19 Using PET/CT
Non-randomizedSingle-groupOpen-labelDiagnostic
Summary
Detection of Integrin avb6 in Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, and Coronavirus Disease 2019 with \[18F\]FP-R01-MG-F2 with PET/CT
Timeline
- Start
- 2017-11-08
- Primary completion
- 2023-04-25
- Completion
- 2025-01-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | [18F]FP-R01-MG-F2 | Peptide | 259 mbq | — |